0887-6924

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 23 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact23 DOIs
2

Attach ORCID iDs across 23 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact23 DOIs
3

Deposit reference lists for 11 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact11 DOIs

DOIs for this ISSN

Showing the top 5 of 23 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Drug-resistance enables selective killing of resistant leuke… (10.1038/sj.leu.2401623)
Abstract References ORCID
114.86 33
2 Leukemic CD3+ LGL share functional properties with their CD8… (10.1038/sj.leu.2401266)
Abstract References ORCID
90.31 15
3 Double minute chromosomes and c-MYC amplification in a child… (10.1038/sj.leu.2401782)
Abstract ORCID
61.52 16
4 Second-generation TKI dasatinib inhibits proliferation of me… (10.1038/leu.2010.84)
Abstract ORCID
57.31 13
5 Gene expression analysis reveals HOX gene upregulation in tr… (10.1038/leu.2010.85)
Abstract ORCID
53.96 11
6 TCR-gamma gene rearrangement with interstitial deletion with… (10.1038/sj.leu.2400903)
Abstract References ORCID
52.42 4
7 Selection of immunoglobulin diversity gene reading frames in… (10.1038/sj.leu.2401396)
Abstract References ORCID
52.42 4
8 Cytogenetic and FISH analysis in five patients with hypoplas… (10.1038/sj.leu.2401827)
Abstract ORCID
45.15 7
9 Calreticulin mutation was rarely detected in patients with m… (10.1038/leu.2014.71)
Abstract ORCID
42.25 6
10 DNA in situ hybridization of individual colonies to determin… (10.1038/sj.leu.2400910)
Abstract References ORCID
35.78 2
11 A role for Danazol in chronic lymphocytic leukemia (10.1038/leu.2011.386)
Abstract ORCID
30.10 3
12 Cardiologist’s perspective to the European LeukemiaNet recom… (10.1038/leu.2016.336)
Abstract ORCID
30.10 3
13 Megakaryocyte colony-forming unit growth is enhanced by alem… (10.1038/sj.leu.2404337)
Abstract ORCID
30.10 3
14 True (10.1038/sj/leu/2401386)
Abstract References ORCID License
30.10 1
15 True (10.1038/sj/leu/2401528)
Abstract References ORCID License
30.10 1
16 Estimating deep molecular responses in chronic myelogenous l… (10.1038/leu.2016.37)
Abstract ORCID
23.86 2
17 Introduction of Ernest Beutler, MD (10.1038/sj.leu.2402054)
Abstract ORCID
23.86 2
18 Expression of retinoic acid receptor–target genes during ret… (10.1038/sj.leu.2402818)
Abstract ORCID
23.86 2
19 Spotlight on molecular targeted therapy: introduction (10.1038/sj.leu.2402418)
Abstract References ORCID
22.58 1
20 Quantifying measurable residual disease correctly (10.1038/s41375-023-02106-5)
Abstract ORCID
0.00 0
21 Abstracts (10.1038/sj.leu.2400997)
Abstract References ORCID
0.00 0
22 Response to Michele Baccarani (10.1038/sj.leu.2401064)
Abstract References ORCID
0.00 0
23 2nd European Workshop On Haploidentical Stem Cell Transplant… (10.1038/sj.leu.2402381)
Abstract References ORCID
0.00 0